Skip to main content
Rene Kahn, MD, Psychiatry, New York, NY, Mount Sinai Beth Israel

ReneSKahnMD

Psychiatry New York, NY

Chair, Department of Psychiatry, Icahn School of Medicine at Mount Sinai

Dr. Kahn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kahn's full profile

Already have an account?

  • Office

    1425 Madison Avenue
    Icahn (East) Building Floor 4th Floor Room Room L4-11
    New York, NY 10029
    Phone(212) 659-8760
    Fax(212) 659-8838
  • Is this information wrong?

Summary

  • Following medical school, I served in the Royal Army of the Netherlands as a first lieutenant, then trained as a psychiatrist in Utrecht and as a neurologist in Amsterdam. I subsequently moved to New York City for a research fellowship in biological psychiatry at Albert Einstein College of Medicine, completed my psychiatry residency at Mount Sinai Hospital, and worked as chief of the psychiatry research unit at the Bronx VA. I moved back to Utrecht in 1993 to be chair of psychiatry at the University Medical Center, and took over leadership of the Brain Center Rudolf Magnus—a hub of research in basic neuroscience, psychiatry, and neurology. In 2017, I returned to Manhattan for my current position, chair of the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai.

    My expertise is in the neurobiology of schizophrenia and other psychotic disorders. One of my most important contributions to the field was helping to establish proof that schizophrenia debuts with cognitive dysfunction, preceding the onset of the first incidence of psychosis by more than a decade. My group also showed that brain volume is one of the most heritable characteristics, paving the way to link brain volumes in health and disease to genetic variation.

    My research has been supported by multiple international grants, and I have served on neuroscience grant review boards in the Netherlands, the United Kingdom, and Germany. I have authored or co-authored more than 900 papers, served on the boards of several international research societies, and received several honors including knighthood in the Netherlands; a honorary doctorate at Semmelweis University in Budapest, Hungary; a Fulbright scholarship and the ECNP’s Neuropsychopharmacology Award.
  • Rene Kahn, MD, PhD

    Esther and Joseph Klingenstein Professor and System Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai.

Education & Training

  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineResidency, Psychiatry, 1988 - 1992
  • University of Groningen Faculty of Medical Science
    University of Groningen Faculty of Medical ScienceClass of 1979

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1993 - 2022
  • CT State Medical License
    CT State Medical License 1992 - 2022

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Accelerating Science to Advance Early Interventions for Schizophrenia
    Accelerating Science to Advance Early Interventions for SchizophreniaOctober 30th, 2020
  • Switching Anti-Psychotic Medications Doesn't Improve Outcomes in First Episode Schizophrenia Patient
    Switching Anti-Psychotic Medications Doesn't Improve Outcomes in First Episode Schizophrenia PatientAugust 14th, 2018
  • No Gain with Antipsych Meds Switch in Schizophrenia
    No Gain with Antipsych Meds Switch in SchizophreniaAugust 13th, 2018
  • Join now to see all

Grant Support

  • Omega fatty aids Trial in Ultra High Risk subjects (PURPOSE)Stanley Foundation2015–2020
  • Innovative Medicine InitiativePRISM2016–2019
  • European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)EGRIS (European Group Research in schizophrenia)2014–2019
  • Genomic studies of bipolar disorder in a large Cohort from The NetherlandsNIH/NIMH2010–2015
  • High-density Genome-wide Association Study inSchizophreniaNIMH2006–2010

Committees

  • Membership Committee, American College of Neuropsychopharmacology 2016 - Present
  • Scientific Advisory Board, MRC Center for Neuropsychiatric Genetics and Genomics, Cardiff, Wales, UK 2015 - Present
  • Member, NEURON (Network of European Funding for Neuroscience Research) 2010 - Present
  • President, Schizophrenia International Research Society (SIRS) 2014 - 2016

Hospital Affiliations